Daekyu Sun - Publications

Affiliations: 
Cancer Biology University of Arizona, Tucson, AZ 
Area:
Cell Biology, Biochemistry, Pharmacology

73/89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Alqahtani T, Kumarasamy VM, Huczyński A, Sun D. Salinomycin and its derivatives as potent RET transcriptional inhibitors for the treatment of medullary thyroid carcinoma. International Journal of Oncology. PMID 31746350 DOI: 10.3892/Ijo.2019.4916  0.353
2019 Sun D. Chromatin Immunoprecipitation Assay to Analyze the Effect of G-Quadruplex Interactive Agents on the Binding of RNA Polymerase II and Transcription Factors to a Target Promoter Region. Methods in Molecular Biology (Clifton, N.J.). 2035: 233-242. PMID 31444753 DOI: 10.1007/978-1-4939-9666-7_13  0.486
2019 Onel B, Wu G, Sun D, Lin C, Yang D. Electrophoretic Mobility Shift Assay and Dimethyl Sulfate Footprinting for Characterization of G-Quadruplexes and G-Quadruplex-Protein Complexes. Methods in Molecular Biology (Clifton, N.J.). 2035: 201-222. PMID 31444751 DOI: 10.1007/978-1-4939-9666-7_11  0.403
2018 Sun D, Kumarasamy VM, Alqahtani T. Abstract 4783: Selective antitumor activity of NSC311152 toward medullary thyroid cancer by downregulating the transcription of RET oncogene Cancer Research. 78: 4783-4783. DOI: 10.1158/1538-7445.Am2018-4783  0.341
2017 Kumarasamy VM, Sun D. Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative. International Journal of Oncology. PMID 28498409 DOI: 10.3892/Ijo.2017.3994  0.476
2015 Kumarasamy VM, Shin YJ, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. Bmc Cancer. 15: 599. PMID 26307103 DOI: 10.1186/S12885-015-1610-5  0.39
2015 Shin YJ, Kumarasamy V, Camacho D, Sun D. Involvement of G-quadruplex structures in regulation of human RET gene expression by small molecules in human medullary thyroid carcinoma TT cells. Oncogene. 34: 1292-9. PMID 24662821 DOI: 10.1038/Onc.2014.65  0.453
2015 Sun D. Transcriptional response of DNA repair genes to DNA damage in cancer cells Journal of Carcinogenesis & Mutagenesis. DOI: 10.4172/1948-5956.S1.001  0.434
2015 Sun D, Kumarasamy V. Abstract 5546: A natural alkaloid, berberine, as a novel transcriptional repressor of RET proto-oncogene in medullary thyroid carcinoma Cancer Research. 75: 5546-5546. DOI: 10.1158/1538-7445.Am2015-5546  0.424
2014 Kumarasamy VM, Shin Y, Sun D. Abstract 3208: Identification and characterization of a small molecule involved in the downregulation of RET transcription in MTC Cancer Research. 74: 3208-3208. DOI: 10.1158/1538-7445.Am2014-3208  0.427
2013 Keerthi K, Rajapakse A, Sun D, Gates KS. Synthesis and characterization of a small analogue of the anticancer natural product leinamycin. Bioorganic & Medicinal Chemistry. 21: 235-41. PMID 23168080 DOI: 10.1016/J.Bmc.2012.10.021  0.352
2013 Uribe DJ, Shin Y, Lau E, Ebbinghaus SW, Sun D. Heterogeneous Nuclear Ribonucleoprotein K Binds to the Cytosine-RichSequence of the Hypoxia Inducible Factor 1 Alpha Proximal Promoterthat forms a Stable i-motif at Neutral pH Journal of Physical Chemistry & Biophysics. 2013: 0-0. DOI: 10.4172/2161-0398.S5-001  0.739
2013 Kumarasamy VM, Sun D. Current and Future Views in G-Quadruplex Secondary Structure as an Anti-Cancer Target Journal of Physical Chemistry & Biophysics. 3: 1-2. DOI: 10.4172/2161-0398.1000E117  0.303
2013 Sinha P, Shin Y, Hays AM, Gates K, Sun D. Cellular responses to the DNA damaging natural compound leinamycin Journal of Cancer Science and Therapy. 5. DOI: 10.4172/1948-5956.S8-003  0.446
2013 Sun D. Transcriptional response of DNA repair genes to DNA damage in cancer cells Journal of Cancer Science & Therapy. DOI: 10.4172/1948-5956.S1.021  0.434
2013 Sun D, Shin Y. Abstract 745: Role of G-quadruplex structures in the human RET promoter region in the regulation of this gene. Cancer Research. 73: 745-745. DOI: 10.1158/1538-7445.Am2013-745  0.471
2012 Viswesh V, Hays AM, Gates K, Sun D. DNA cleavage induced by antitumor antibiotic leinamycin and its biological consequences Bioorganic and Medicinal Chemistry. 20: 4413-4421. PMID 22682923 DOI: 10.1016/J.Bmc.2012.05.033  0.398
2011 Uribe DJ, Guo K, Shin YJ, Sun D. Heterogeneous nuclear ribonucleoprotein K and nucleolin as transcriptional activators of the vascular endothelial growth factor promoter through interaction with secondary DNA structures. Biochemistry. 50: 3796-806. PMID 21466159 DOI: 10.1021/Bi101633B  0.766
2011 Sun D, Guo K, Shin YJ. Evidence of the formation of G-quadruplex structures in the promoter region of the human vascular endothelial growth factor gene. Nucleic Acids Research. 39: 1256-65. PMID 20959293 DOI: 10.1093/Nar/Gkq926  0.54
2011 Sun D, Shin Y, Uribe D. Abstract A140: Development of high-throughput assay for new agents that inhibit the transcription of the HIF-1alpha gene. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A140  0.724
2010 Zheng J, Liu X, Yuan Q, Shin YJ, Sun D, Lu Y. Thiol-dependent DNA cleavage by aminomethylated Beaucage's reagent. Organic & Biomolecular Chemistry. 8: 1293-5. PMID 20204198 DOI: 10.1039/B926217B  0.407
2010 Viswesh V, Gates K, Sun D. Characterization of DNA damage induced by a natural product antitumor antibiotic leinamycin in human cancer cells Chemical Research in Toxicology. 23: 99-107. PMID 20017514 DOI: 10.1021/Tx900301R  0.434
2010 Sun D, Hurley LH. Biochemical techniques for the characterization of G-quadruplex structures: EMSA, DMS footprinting, and DNA polymerase stop assay. Methods in Molecular Biology (Clifton, N.J.). 608: 65-79. PMID 20012416 DOI: 10.1007/978-1-59745-363-9_5  0.525
2010 Sun D. In vitro footprinting of promoter regions within supercoiled plasmid DNA. Methods in Molecular Biology (Clifton, N.J.). 613: 223-33. PMID 19997887 DOI: 10.1007/978-1-60327-418-0_14  0.533
2009 González V, Guo K, Hurley L, Sun D. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. The Journal of Biological Chemistry. 284: 23622-35. PMID 19581307 DOI: 10.1074/Jbc.M109.018028  0.435
2009 Dexheimer TS, Carey SS, Zuohe S, Gokhale VM, Hu X, Murata LB, Maes EM, Weichsel A, Sun D, Meuillet EJ, Montfort WR, Hurley LH. NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III(1). Molecular Cancer Therapeutics. 8: 1363-77. PMID 19435876 DOI: 10.1158/1535-7163.Mct-08-1093  0.487
2009 Sun D, Hurley LH. The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression. Journal of Medicinal Chemistry. 52: 2863-74. PMID 19385599 DOI: 10.1021/Jm900055S  0.505
2009 Uribe DJ, Guo K, Shin Y, Hurley L, Sun D. Abstract A203: Heterogeneous nuclear ribonucleoprotein K (hnRNP K) binds to the vascular endothelial growth factor (VEGF) promoter and plays a role in its transcriptional control Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A203  0.747
2008 Guo K, Gokhale V, Hurley LH, Sun D. Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene. Nucleic Acids Research. 36: 4598-608. PMID 18614607 DOI: 10.1093/Nar/Gkn380  0.495
2008 Sun D, Liu WJ, Guo K, Rusche JJ, Ebbinghaus S, Gokhale V, Hurley LH. The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. Molecular Cancer Therapeutics. 7: 880-9. PMID 18413801 DOI: 10.1158/1535-7163.Mct-07-2119  0.504
2007 Qin Y, Rezler EM, Gokhale V, Sun D, Hurley LH. Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4. Nucleic Acids Research. 35: 7698-713. PMID 17984069 DOI: 10.1093/Nar/Gkm538  0.483
2007 Guo K, Pourpak A, Beetz-Rogers K, Gokhale V, Sun D, Hurley LH. Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene. Journal of the American Chemical Society. 129: 10220-8. PMID 17672459 DOI: 10.1021/Ja072185G  0.444
2006 Dexheimer TS, Sun D, Hurley LH. Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter. Journal of the American Chemical Society. 128: 5404-15. PMID 16620112 DOI: 10.1021/Ja0563861  0.452
2005 Liu W, Sun D, Hurley LH. Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells. Nucleosides, Nucleotides & Nucleic Acids. 24: 1801-15. PMID 16438049 DOI: 10.1080/15257770500267238  0.366
2005 De Armond R, Wood S, Sun D, Hurley LH, Ebbinghaus SW. Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter. Biochemistry. 44: 16341-50. PMID 16331995 DOI: 10.1021/Bi051618U  0.435
2005 Sun D, Guo K, Rusche JJ, Hurley LH. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Research. 33: 6070-80. PMID 16239639 DOI: 10.1093/Nar/Gki917  0.499
2005 Seenisamy J, Bashyam S, Gokhale V, Vankayalapati H, Sun D, Siddiqui-Jain A, Streiner N, Shin-Ya K, White E, Wilson WD, Hurley LH. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. Journal of the American Chemical Society. 127: 2944-59. PMID 15740131 DOI: 10.1021/Ja0444482  0.419
2004 Bassett S, Urrabaz R, Sun D. Cellular response and molecular mechanism of antitumor activity by leinamycin in MiaPaCa human pancreatic cancer cells. Anti-Cancer Drugs. 15: 689-96. PMID 15269600 DOI: 10.1097/01.Cad.0000136886.72917.6F  0.425
2004 Sun D, Urrabaz R. Development of non-electrophoretic assay method for DNA ligases and its application to screening of chemical inhibitors of DNA ligase I. Journal of Biochemical and Biophysical Methods. 59: 49-59. PMID 15134906 DOI: 10.1016/S0165-022X(02)00071-4  0.391
2002 Sun D, Urrabaz R, Buzello C, Nguyen M. Effects of cisplatin on expression of DNA ligases in MiaPaCa human pancreatic cancer cells. Biochemical and Biophysical Research Communications. 298: 537-44. PMID 12408985 DOI: 10.1016/S0006-291X(02)02493-2  0.419
2002 Sun D, Urrabaz R, Buzello C, Nguyen M. Induction of DNA ligase I by 1-beta-D-arabinosylcytosine and aphidicolin in MiaPaCa human pancreatic cancer cells. Experimental Cell Research. 280: 90-6. PMID 12372342 DOI: 10.1006/Excr.2002.5625  0.424
2002 Sun D, Urrabaz R, Kelly S, Nguyen M, Weitman S. Enhancement of DNA ligase I level by gemcitabine in human cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1189-95. PMID 11948132  0.306
2001 Shi DF, Wheelhouse RT, Sun D, Hurley LH. Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. Journal of Medicinal Chemistry. 44: 4509-23. PMID 11741471 DOI: 10.1021/Jm010246U  0.391
2001 Kerwin SM, Sun D, Kern JT, Rangan A, Thomas PW. G-quadruplex DNA binding by a series of carbocyanine dyes Bioorganic and Medicinal Chemistry Letters. 11: 2411-2414. PMID 11549435 DOI: 10.1016/S0960-894X(01)00490-5  0.455
2001 Sun D, Hurley LH. Targeting telomeres and telomerase. Methods in Enzymology. 340: 573-92. PMID 11494871 DOI: 10.1016/S0076-6879(01)40443-5  0.414
2000 Hurley LH, Wheelhouse RT, Sun D, Kerwin SM, Salazar M, Fedoroff OY, Han FX, Han H, Izbicka E, Von Hoff DD. G-quadruplexes as targets for drug design. Pharmacology & Therapeutics. 85: 141-58. PMID 10739869 DOI: 10.1016/S0163-7258(99)00068-6  0.429
1999 Raymond E, Sun D, Izbicka E, Mangold G, Silvas E, Windle B, Sharma S, Soda H, Laurence R, Davidson K, Hoff DDV. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. British Journal of Cancer. 80: 1332-1341. PMID 10424733 DOI: 10.1038/Sj.Bjc.6690526  0.321
1999 Sun D, Lopez-Guajardo CC, Quada J, Hurley LH, Von Hoff DD. Regulation of catalytic activity and processivity of human telomerase. Biochemistry. 38: 4037-44. PMID 10194316 DOI: 10.1021/Bi982249N  0.441
1998 Fletcher TM, Sun D, Salazar M, Hurley LH. Effect of DNA secondary structure on human telomerase activity. Biochemistry. 37: 5536-41. PMID 9548937 DOI: 10.1021/Bi972681P  0.443
1998 Wheelhouse RT, Sun D, Han H, Han FX, Hurley LH. Cationic porphyrins as telomerase inhibitors: The interaction of tetra- (N-methyl-4-pyridyl)porphine with quadruplex DNA [1] Journal of the American Chemical Society. 120: 3261-3262. DOI: 10.1021/Ja973792E  0.358
1997 Sun D, Thompson B, Cathers BE, Salazar M, Kerwin SM, Trent JO, Jenkins TC, Neidle S, Hurley LH. Inhibition of human telomerase by a G-quadruplex-interactive compound. Journal of Medicinal Chemistry. 40: 2113-6. PMID 9216827 DOI: 10.1021/Jm970199Z  0.305
1997 Lee SJ, Seaman FC, Sun D, Xiong H, Kelly RC, Hurley LH. Replacement of the Bizelesin ureadiyl linkage by a guanidinium moiety retards translocation from monoalkylation to cross-linking sites on DNA Journal of the American Chemical Society. 119: 3434-3442. DOI: 10.1021/Ja963873V  0.378
1996 Raymond E, Sun D, Chen SF, Windle B, Hoff DDV. Agents that target telomerase and telomeres Current Opinion in Biotechnology. 7: 583-591. PMID 8939642 DOI: 10.1016/S0958-1669(96)80068-1  0.377
1996 Sun D, Hurley LH, Harshey RM. Structural distortions induced by integration host factor (IHF) at the H' site of phage lambda probed by (+)-CC-1065, pluramycin, and KMnO4 and by DNA cyclization studies. Biochemistry. 35: 10815-27. PMID 8718873 DOI: 10.1021/Bi952786X  0.458
1995 Sun D, Hurley LH. TBP binding to the TATA box induces a specific downstream unwinding site that is targeted by pluramycin. Chemistry & Biology. 2: 457-69. PMID 9383448 DOI: 10.1016/1074-5521(95)90263-5  0.485
1995 Fan JY, Sun D, Yu H, Kerwin SM, Hurley LH. Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. Journal of Medicinal Chemistry. 38: 408-24. PMID 7853333 DOI: 10.1021/Jm00003A003  0.401
1995 Thompson AS, Fan JY, Sun D, Hansen M, Hurley LH. Determination of the structural role of the internal guanine-cytosine base pair in recognition of a seven-base-pair sequence cross-linked by bizelesin. Biochemistry. 34: 11005-16. PMID 7669758 DOI: 10.1021/Bi00035A006  0.379
1995 Sun D, Hansen M, Hurley L. Molecular Basis for the DNA Sequence Specificity of the Pluramycins. A Novel Mechanism Involving Groove Interactions Transmitted through the Helix via Intercalation To Achieve Sequence Selectivity at the Covalent Bonding Step Journal of the American Chemical Society. 117: 2430-2440. DOI: 10.1021/Ja00114A007  0.381
1995 Thompson AS, Sun D, Hurley LH. Monoalkylation and cross-linking of DNA by cyclopropapyrroloindoles entraps bent and straight forms of A-tracts Journal of the American Chemical Society. 117: 2371-2372. DOI: 10.1021/Ja00113A035  0.376
1994 Sun D, Hurley LH. Cooperative bending of the 21-base-pair repeats of the SV40 viral early promoter by human Sp1. Biochemistry. 33: 9578-87. PMID 8068633 DOI: 10.1021/Bi00198A025  0.484
1994 Sun D, Hurley LH. Binding of Sp1 to the 21-bp repeat region of SV40 DNA: effect of intrinsic and drug-induced DNA bending between GC boxes. Gene. 149: 165-72. PMID 7958981 DOI: 10.1016/0378-1119(94)90425-1  0.466
1994 Hurley LH, Sun D. (+)-CC-1065 as a probe for intrinsic and protein-induced bending of DNA. Journal of Molecular Recognition : Jmr. 7: 123-32. PMID 7826672 DOI: 10.1002/Jmr.300070209  0.465
1993 Sun D, Lin CH, Hurley LH. A-tract and (+)-CC-1065-induced bending of DNA. Comparison of structural features using non-denaturing gel analysis, hydroxyl-radical footprinting, and high-field NMR. Biochemistry. 32: 4487-95. PMID 8387334 DOI: 10.1021/Bi00068A003  0.388
1993 Sun D, Hansen M, Clement JJ, Hurley LH. Structure of the altromycin B (N7-guanine)-DNA adduct. A proposed prototypic DNA adduct structure for the pluramycin antitumor antibiotics. Biochemistry. 32: 8068-74. PMID 8347608 DOI: 10.1021/Bi00083A003  0.414
1993 Aristoff PA, Johnson PD, Sun D, Hurley LH. Synthesis and biochemical evaluation of the CBI-PDE-I-dimer, a benzannelated analog of (+)-CC-1065 that also produces delayed toxicity in mice. Journal of Medicinal Chemistry. 36: 1956-63. PMID 8336335 DOI: 10.1021/Jm00066A004  0.357
1993 Sun D, Park HJ, Hurley LH. Alkylation of guanine and cytosine in DNA by bizelesin. Evidence for a covalent immobilization leading to a proximity-driven alkylation of normally unreactive bases by a (+)-CC-1065 cross-linking compound. Chemical Research in Toxicology. 6: 889-94. PMID 8117929 DOI: 10.1021/Tx00036A020  0.402
1993 Sun D, Hurley LH. Analysis of the monoalkylation and cross-linking sequence specificity of bizelesin, a bifunctional alkylation agent related to (+)-CC-1065 Journal of the American Chemical Society. 115: 5925-5933. DOI: 10.1021/Ja00067A005  0.397
1992 Sun D, Hurley LH. Structure-activity relationships of (+)-CC-1065 analogues in the inhibition of helicase-catalyzed unwinding of duplex DNA. Journal of Medicinal Chemistry. 35: 1773-82. PMID 1588557 DOI: 10.1021/Jm00088A012  0.451
1992 Sun D, Hurley LH. Effect of the (+)-CC-1065-(N3-adenine)DNA adduct on in vitro DNA synthesis mediated by Escherichia coli DNA polymerase. Biochemistry. 31: 2822-9. PMID 1547223 DOI: 10.1021/Bi00125A025  0.455
1992 Maine IP, Sun D, Hurley LH, Kodadek T. The antitumor agent CC-1065 inhibits helicase-catalyzed unwinding of duplex DNA. Biochemistry. 31: 3968-75. PMID 1314652 DOI: 10.1021/Bi00131A012  0.375
1992 Maine IP, Sun D, Hurley LH, Kodadek T. The antitumor agent CC-1065 inhibits helicase-catalyzed unwinding of duplex DNA. [Erratum to document cited in CA116(23):227766s] Biochemistry. 31: 10642-10642. DOI: 10.1021/Bi00158A029  0.349
1991 Lee CS, Sun D, Kizu R, Hurley LH. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA. Chemical Research in Toxicology. 4: 203-13. PMID 1782349 DOI: 10.1021/Tx00020A013  0.461
1991 Lin CH, Sun DY, Hurley LH. (+)-CC-1065 produces bending of DNA that appears to resemble adenine/thymine tracts. Chemical Research in Toxicology. 4: 21-6. PMID 1655087 DOI: 10.1021/Tx00019A003  0.419
Low-probability matches (unlikely to be authored by this person)
1998 Sun D, Hurley LH, Von Hoff DD. Telomerase assay using biotinylated-primer extension and magnetic separation of the products. Biotechniques. 25: 1046-51. PMID 9863060 DOI: 10.2144/98256Cr03  0.294
1998 Sharma S, Raymond E, Soda H, Sun D, Hilsenbeck SG, Sharma A, Izbicka E, Windle B, Von Hoff DD. Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 8: 1063-74. PMID 9426325 DOI: 10.1023/A:1008206420505  0.282
1993 Sun D, Hurley L. Additions and Corrections: Analysis of the Monoalkylation and Cross-Linking Sequence Specificity of Bizelesin, a Bifunctional Alkylation Agent Related to (+)-CC-1065 (J. Am. Chem. Soc., (1993) 115(20)(9355)) Journal of the American Chemical Society. 115. DOI: 10.1021/Ja00073A601  0.28
2023 Alqahtani T, Kumarasamy V, Alghamdi SS, Suliman RS, Bin Saleh K, Alrashed MA, Aldhaeefi M, Sun D. Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes. Cancers. 15. PMID 37046823 DOI: 10.3390/cancers15072163  0.275
2012 Sivaramakrishnan S, Breydo L, Sun D, Gates KS. The macrocycle of leinamycin imparts hydrolytic stability to the thiol-sensing 1,2-dithiolan-3-one 1-oxide unit of the natural product. Bioorganic & Medicinal Chemistry Letters. 22: 3791-4. PMID 22560586 DOI: 10.1016/J.Bmcl.2012.04.003  0.274
2002 Sun D. Biotinylated primer for detecting telomerase activity without amplification. Methods in Molecular Biology (Clifton, N.J.). 191: 165-71. PMID 11951605 DOI: 10.1385/1-59259-189-2:165  0.247
2012 Sun DQ, Wang Y, Liu DG. Cancer cell growth suppression by a 62nt AU-rich RNA from C/EBPβ 3'UTR through competitive binding with HuR. Biochemical and Biophysical Research Communications. 426: 122-8. PMID 22921787 DOI: 10.1016/j.bbrc.2012.08.049  0.227
2010 Sun D, Melman G, Letourneau NJ, Hays AM, Melman A. Synthesis and antiproliferating activity of iron chelators of hydroxyamino-1,3,5-triazine family. Bioorganic & Medicinal Chemistry Letters. 20: 458-60. PMID 20005708 DOI: 10.1016/J.Bmcl.2009.11.130  0.215
2021 Alqahtani T, Alswied A, Sun D. Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity. Cancers. 13. PMID 34209165 DOI: 10.3390/cancers13133288  0.213
2013 Sun DQ, Wang Y, Liu DG. Overexpression of hnRNPC2 induces multinucleation by repression of Aurora B in hepatocellular carcinoma cells. Oncology Letters. 5: 1243-1249. PMID 23599772 DOI: 10.3892/ol.2013.1167  0.183
2011 Wang Y, Sun DQ, Liu DG. Tumor suppression by RNA from C/EBPβ 3'UTR through the inhibition of protein kinase Cε activity. Plos One. 6: e16543. PMID 21283634 DOI: 10.1371/journal.pone.0016543  0.148
2010 WANG H, WANG Y, SUN D, LIU D. Molecular Mechanism of Tumor Suppression Activity of C/EBPβ mRNA 3′UTR: Simultaneous Deletion of 3 Short Sequences in The 3'UTR Reduces Its Tumor Suppression Activity* Progress in Biochemistry and Biophysics. 36: 1134-1140. DOI: 10.3724/sp.j.1206.2009.00144  0.14
2013 SUN D, WANG Y, LIU D. Purification and Analysis of A/U-rich RNA Binding Protein Using Immobilized RNA by EDC Crosslinking Acta Agronomica Sinica. 40: 386. DOI: 10.3724/SP.J.1206.2012.00309  0.116
2017 McConnell N, Xu Z, Kumarasamy V, Sun D, Frett B, Li HY. Synthesis of Constrained Heterocycles Employing Two Post-Ugi Cyclization Methods for Rapid Library Generation with In Cellulo Activity. Chemistryselect. 2: 11821-11825. PMID 30140731 DOI: 10.1002/slct.201702179  0.086
2015 Kumarasamy VM, Shin YJ, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine Bmc Cancer. 15. DOI: 10.1186/s12885-015-1610-5  0.069
2011 WANG Y, SUN D, LIU D. A Simple Method to Raise Efficiency of Interaction With Nucleic Acids of Self Polymerization-prone Proteins Progress in Biochemistry and Biophysics. 38: 173-176. DOI: 10.3724/SP.J.1206.2010.00358  0.041
Hide low-probability matches.